4//SEC Filing
Quimi Daphne 4
Accession 0000950170-24-061294
CIK 0001658551other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 7:37 PM ET
Size
5.7 KB
Accession
0000950170-24-061294
Insider Transaction Report
Form 4
Quimi Daphne
Director
Transactions
- Purchase
Common Stock
2024-05-14$1.89/sh+2,750$5,184→ 2,750 total - Purchase
Common Stock
2024-05-15$1.89/sh+2,250$4,252→ 5,000 total
Documents
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeother
Related Parties
1- filerCIK 0001543031
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 7:37 PM ET
- Size
- 5.7 KB